COVID-19: A New Challenge in Pregnancy and Heart Disease

 DOI: 10.36660/abc.20200511
Peripheral facial paralysis as presenting symptom of COVID-19 in a
pregnant woman
 DOI: 10.1136/bcr-2020-237146
COVID-19 in pregnancy: Placental and neonatal involvement
 DOI: 10.1111/aji.13306
Obesity as a contributor to immunopathology in pregnant and non-
pregnant adults with COVID-19
 DOI: 10.1111/aji.13320
Potential effects of SARS-CoV-2 infection during pregnancy on
fetuses and newborns are worthy of attention
 DOI: 10.1111/jog.14406
COVID-19 and pregnancy: A review of clinical characteristics,
obstetric outcomes and vertical transmission
 DOI: 10.1111/ajo.13204
Is Pregnancy an Immunological Contributor to Severe or Controlled
COVID-19 Disease?
 DOI: 10.1111/aji.13317
COVID-19 and maternal, fetal and neonatal mortality: a systematic
review
 DOI: 10.1080/14767058.2020.1806817
Clinical characteristics and risk factors for mortality in obstetric
patients with severe COVID-19 in Brazil: a surveillance database
analysis
 DOI: 10.1111/1471-0528.16470
Maternal COVID-19 infection, clinical characteristics, pregnancy,
and neonatal outcome: A prospective cohort study
 DOI: 10.1016/j.ejogrb.2020.07.008
Fetal deaths in pregnancies with SARS-CoV-2 infection in Brazil: A
case series
 DOI: 10.1016/j.crwh.2020.e00243
SARS-CoV-2 in pregnancy: characteristics and outcomes of
hospitalized and non-hospitalized women due to COVID-19
 DOI: 10.1080/14767058.2020.1793320
Characteristics and Outcomes of 241 Births to Women With Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection
at Five New York City Medical Centers
 DOI: 10.1097/AOG.0000000000004025
Coronavirus disease 2019 in pregnancy was associated with
maternal morbidity and preterm birth
 DOI: 10.1016/j.ajog.2020.06.022
Characteristics and outcomes of pregnant women admitted to
hospital with confirmed SARS-CoV-2 infection in UK: national
population based cohort study
 DOI: 10.1136/bmj.m2107
Early-onset symptomatic neonatal COVID-19 infection with high
probability of vertical transmission
 DOI: 10.1007/s15010-020-01493-6
 Clinical characteristics and intrauterine vertical transmission
potential of COVID-19 infection in nine pregnant women: a
retrospective review of medical records
 DOI: 10.1016/S0140-6736(20)30360-3
Clinical Characteristics of Pregnant Women with Covid-19 in
Wuhan, China
 DOI: 10.1056/NEJMc2009226
Two cases of coronavirus 2019-related cardiomyopathy in pregnancy
 DOI: 10.1016/j.ajogmf.2020.100113
Antibodies in Infants Born to Mothers With COVID-19 Pneumonia
 DOI: 10.1001/jama.2020.4861
An update on SARS-CoV-2/COVID-19 with particular reference to its
clinical pathology, pathogenesis, immunopathology and mitigation
strategies
 DOI: 10.1016/j.tmaid.2020.101755
Clinical course and risk factors for mortality of adult inpatients with
COVID-19 in Wuhan, China: a retrospective cohort study
DOI: https://doi.org/10.1016/S0140-6736(20)30566-3

Effects of Maternal Obesity and Gestational Diabetes Mellitus on the

Placenta: Current Knowledge and Targets for Therapeutic
Interventions
 DOI: 10.2174/1570161118666200616144512
Association between prepregnancy body mass index and risk of
congenital heart defects in offspring: an ambispective observational
study in China
 DOI: 10.1186/s12884-020-03100-w
Impact of maternal diabetes and obesity on fetal cardiac functions
 DOI: 10.1186/s43044-020-00077-x
Obstetric and intensive-care strategies in a high-risk pregnancy with
critical respiratory failure due to COVID-19: A case report
 DOI: 10.1016/j.crwh.2020.e00240
Obesity and gestational diabetes in pregnant care and clinical
practice
 DOI: 10.2174/1570161118666200628142353
Placental Nutrient Transport in Gestational Diabetic Pregnancies
 DOI: 10.3389/fendo.2017.00306
Placental function in maternal obesity
 DOI: 10.1042/CS20190266
Obesity and COVID-19: A Perspective from the European Association
for the Study of Obesity on Immunological Perturbations,
Therapeutic Challenges, and Opportunities in Obesity
 DOI: 10.1159/000510719